NASDAQ | TSX: ACB
EDMONTON, AB, July 29,
2024 /CNW/ - Aurora Cannabis Inc. (the "Company"
or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company,
announced today that it has scheduled a conference call to discuss
the results for its first quarter 2025 on Wednesday, August 7, 2024 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report
its financial results for the first quarter 2025 before the opening
of markets that same day.
Conference Call Details
DATE:
|
Wednesday, August 7,
2024
|
TIME:
|
8:00 a.m. Eastern Time
| 6:00 a.m. Mountain Time
|
WEBCAST:
|
Click Here
|
Miguel Martin, Chief Executive
Officer, and Simona King, Chief
Financial Officer, will host the conference call and question and
answer period. This weblink has also been posted to the Company's
"Investor Info" link at
https://www.auroramj.com/investors/ under "Events".
About Aurora Cannabis
Aurora is opening the world to cannabis, serving both the
medical and consumer markets
across Canada, Europe, Australia and South America. Headquartered
in Edmonton, Alberta, Aurora is a
pioneer in global cannabis, dedicated to helping people improve
their lives. The Company's adult- use brand portfolio includes
Aurora Drift, San Rafael '71, Daily Special, Tasty's, Being and
Greybeard. Medical cannabis brands include MedReleaf, CanniMed,
Aurora and Whistler Medical Marijuana Co, as well as international
brands, Pedanios, Bidiol, IndiMed and CraftPlant. Aurora also has a
controlling interest in Bevo Farms Ltd., North America's leading
supplier of propagated agricultural plants. Driven by science and
innovation, and with a focus on high-quality cannabis products,
Aurora's brands continue to break through as industry leaders in
the medical, wellness and adult recreational markets wherever they
are launched. Learn more at www.aurora. Learn more
at www.auroramj.com and follow us
on X and LinkedIn.
Aurora's common shares trade on the NASDAQ and TSX under the
symbol "ACB".
Forward Looking Statements
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"). Forward- looking
statements are frequently characterized by words such as "plan",
"continue", "expect", "project", "intend", "believe", "anticipate",
"estimate", "may", "will", "potential", "proposed" and other
similar words, or statements that certain events or conditions
"may" or "will" occur. Forward-looking statements made in this news
release include statements regarding timing of the release of the
Company's financial statements for first quarter 2025 ended
June 30, 2024 and scheduling of the
conference call to discuss results.
These forward-looking statements are only predictions. Forward
looking information or statements contained in this news release
have been developed based on assumptions management considers to be
reasonable. Material factors or assumptions involved in developing
forward-looking statements include, without limitation, publicly
available information from governmental sources as well as from
market research and industry analysis and on assumptions based on
data and knowledge of this industry which the Company believes to
be reasonable. Forward-looking statements are subject to a variety
of risks, uncertainties and other factors that management believes
to be relevant and reasonable in the circumstances could cause
actual events, results, level of activity, performance, prospects,
opportunities or achievements to differ materially from those
projected in the forward-looking statements. These risks include,
but are not limited to, the ability to retain key personnel, the
ability to continue investing in infrastructure to support growth,
the ability to obtain financing on acceptable terms, the continued
quality of our products, customer experience and retention, the
development of third party government and nongovernment consumer
sales channels, management's estimates of consumer demand in
Canada and in jurisdictions where
the Company exports, expectations of future results and expenses,
the risk of successful integration of acquired business and
operations, management's estimation that SG&A will grow
only in proportion of revenue growth, the ability to expand and
maintain distribution capabilities, the impact of competition, the
general impact of financial market conditions, the yield from
cannabis growing operations, product demand, changes in prices of
required commodities, competition, and the possibility for changes
in laws, rules, and regulations in the industry, epidemics,
pandemics or other public health crises, and other risks,
uncertainties and factors set out under the heading "Risk Factors"
in the Company's annual information form dated June 20, 2024 (the "AIF") and filed with Canadian
securities regulators available on the Company's issuer profile on
SEDAR at www.sedarplus.com and filed with and available on the
SEC's website at www.sec.gov. The Company cautions that the list of
risks, uncertainties and other factors described in the AIF is not
exhaustive and other factors could also adversely affect its
results. Readers are urged to consider the risks, uncertainties and
assumptions carefully in evaluating the forward-looking statements
and are cautioned not to place undue reliance on such information.
The Company is under no obligation, and expressly disclaims any
intention or obligation, to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise, except as expressly required by applicable securities
law.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/aurora-cannabis-to-host-first-quarter-2025-investor-conference-call-302208368.html
SOURCE Aurora Cannabis Inc.